To investigate if oral, nonabsorbable antibiotics prevent bacterial infections in cirrhotics with gastrointestinal hemorrhage, 140 consecutive patients were randomly allocated into two groups: 68 patients (Group I) were given oral, non absorbable antibiotics (gentamicin + vancomycin + nystatin or ne
Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
β Scribed by Marcel Blaise; Dominique Pateron; Jean-Claude Trinchet; Serge Levacher; Michel Beaugrand; Jean-Louis Pourriat
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 504 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
This randomized prospective study was aimed at assessing the efficiency of a systemic antibiotic therapy for the prevention of bacterial infections in cirrhotic patients with gastrointestinal hemorrhage by ruptured esophageal varices. For 15 mo, all patients hospitalized with no infection on admission, were included in the study. Starting on admission day, patients in group A received ofloxacin (400 mglday) for 10 days, first intravenously then orally. They also received an intravenous bolus of amoxicillin plus clavulanic acid (1 g) before each endoscopy performed during hemorrhage. Patients in group B received antibiotic therapy only in cases of established or suspected infection. Chest X-ray, blood culture, urine culture and sputum and ascitic fluid culture were performed every day for 7 days, then every other day for the next 7 days. A bronchial sampling was performed with the Wimberley technique on patients with endotracheal intubation. Ninety-one patients (55 men, 54 2 11 years, 78% Child Pugh class C) were included in the study (46 in group A, 45 in group B). Group A showed a lower incidence of bacterial infections than group B (20% vs. 66%; p < 0.001). Breakdown of positive bacteriological sampling was as follows: blood (6 vs. 17), ascites (3 vs. 7), lungs (2 vs. 18), urine (1 vs. 10).
The 2-wk mortality rate was 24% in group A and 35% in group B. (HEPATOLOGY 1994;2034-38.) PATIENTS AND METHODS From September 1990 to January 1992, all cirrhotic patients more than 18 years of age hospitalized in intensive care units for upper gastrointestinal hemorrhage, who reization and who had no infection on admission were included in our study. Each patient or family gave informed consent and
π SIMILAR VOLUMES
of the bleeding. In patients with serum creatinine level ΓΊ200 mmol/ L, doses were reduced to amoxicillin plus clavulanic acid (Augmentin, Beecham, Nanterre, France) 500 mg/100 kg twice daily and ciproflox-From the Unite Β΄de Soins Intensifs, Service d'He Β΄pato-Gastroente Β΄rologie, Ho Λpital Saintacin
In cirrhotic patients with gastrointestinal bleeding, antibiotic prophylaxis decreases the incidence of infections but most randomized trials have not shown an increase in survival. The aim of this meta-analysis was to assess the efficacy of antibiotic prophylaxis in the prevention of infections and